Creutzfeldt-Jakob disease: therapeutic strategies

By Beringue V.   Deslys J-P.   Adjou K.T.   Dormont D.  

Expert Opinion on Investigational Drugs, Vol. 6, Iss. 4, 1997-04 ,pp. : 345-348

Informa Healthcare

Access to resources Recommend Favorite

Somatropin: Creutzfeldt-Jakob disease: case report

By  

Reactions Weekly, Vol. 1, Iss. 1196, 2008-01 ,pp. : 34-35

Adis International

Access to resources Recommend Favorite

Homozygosity at prion protein gene codon 129 increases somatropin-transmitted Creutzfeldt-Jakob disease (CJD) risk

By  

Inpharma, Vol. 1, Iss. 1396, 2003-01 ,pp. : 21-21

Adis International

Access to resources Recommend Favorite

Therapeutic approaches in treating Creutzfeldt-Jakob disease – what does the future hold?

By Croes Esther A  

Expert Opinion on Pharmacotherapy, Vol. 5, Iss. 11, 2004-11 ,pp. : 2391-2396

Informa Healthcare

Access to resources Recommend Favorite

Possible Editing of Alu Transcripts in Blood Cells of Sporadic Creutzfeldt-Jakob Disease (sCJD)

By Kiesel Petra   Gibson Toby   Ciesielczyk Barbara   Bodemer Monika   Kaup Franz-Josef   Bodemer Walter   Zischler Hans   Zerr Inga  

Journal of Toxicology and Environmental Health, Vol. 74, Iss. 2-4, 2011-01 ,pp. : 88-95

Taylor & Francis Ltd

Access to resources Recommend Favorite